New York, April 15, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Oligonucleotide Synthesis Market by Product, Type, Application, Research, Diagnostic), End User - ...

New York, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Oligonucleotide Therapy Global Market Report 2023" - https://www ...

Denali expects to continue expanding its TV-enabled pipeline across enzyme, antibody, and oligonucleotide franchises, bringing forward one to two ...

The Swiss pharma is paying $12 billion for Avidity Biosciences and its three late-stage antibody oligonucleotide conjugates.

The use of oligonucleotides as therapeutic agents is of great interest, particularly when it comes to siRNA and antisense oligonucleotides. However, the difficulty of targeting the right organ and ...

Growing Importance of Peptide & Oligonucleotide TherapeuticsPeptides and oligonucleotides are transforming modern medicine.

Oligonucleotide therapeutics, which can modulate gene expression by a variety of mechanisms, have the potential to treat numerous diseases. Although several oligonucleotide-based drugs have recently ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Judo Bio, a biotechnology company pioneering oligonucleotide medicines delivered to the kidney, today announced the company’s launch and $100 million in initial ...

The collaboration will utilise Lundbeck's neuroscience experience and Contera Pharma's oligonucleotide expertise.

Oligonucleotide therapeutics make up a small but rapidly growing segment of the overall global drug pipeline, with 245 programs currently in development today. While only one approved oligo ...

The global oligonucleotide API market is poised to grow from USD 2.81 billion in 2024 to USD 4.84 billion by 2034, expanding at a CAGR of 5.60%. The increasing need for innovative drug classes and ...